首页> 外文期刊>Cancers >A Retrospective Dosimetric Study of Radiotherapy Patients with Left-Sided Breast Cancer; Patient Selection Criteria for Deep Inspiration Breath Hold Technique
【24h】

A Retrospective Dosimetric Study of Radiotherapy Patients with Left-Sided Breast Cancer; Patient Selection Criteria for Deep Inspiration Breath Hold Technique

机译:回顾性放射学研究,研究了放疗的左乳腺癌患者。深度吸气屏气技术的患者选择标准

获取原文
获取外文期刊封面目录资料

摘要

Background: Several studies have investigated cardiac dose reduction when utilizing the deep inspiration breath hold (DIBH) technique in patients undergoing radiotherapy for left-sided breast cancer. This paper aims to recommend potential selection criteria based on a retrospective single institute study of free breathing (FB) and DIBH computed tomography (CT) simulation planning scans. Methods: Dosimetric comparisons were performed retrospectively for 20 patients correlating the dose reduction and patient anatomical factors (anatomical variation of chest shape, chest wall separation, total lung volume (TLV) and others). Results: Paired t-tests demonstrated significant cardiac dose reduction for most patients but not all. Minimal cardiac dose reduction was observed for three patients using their DIBH plan, with one patient receiving a higher dose. Linear regression analysis identified a positive correlation between the patient’s TLV (on the FB CT simulation scan) and the magnitude of dosimetric benefit received (0.4045 R 2 ). Conclusion: The TLV measured on a FB plan could potentially be utilised to predict cardiac exposure and assist with patient selection for DIBH. This is important in resource allocation, as DIBH may be unnecessarily recommended for some patients with little dosimetric benefit.
机译:背景:几项研究已经研究了在接受深部吸气屏气(DIBH)技术的左侧乳腺癌放疗患者中降低心脏剂量的方法。本文旨在根据对自由呼吸(FB)和DIBH计算机断层摄影(CT)模拟计划扫描的回顾性单机构研究来推荐潜在的选择标准。方法:回顾性比较了20例与剂量减少和患者的解剖因素(胸部形状,胸壁分离,总肺体积(TLV)等)相关的患者的剂量学比较。结果:配对t检验显示,大多数患者(但不是全部)的心脏剂量明显降低。使用他们的DIBH计划,三名患者观察到最小的心脏剂量减少,一名患者接受了更高的剂量。线性回归分析确定了患者的TLV(在FB CT模拟扫描中)与所获得的剂量学益处(0.4045 R 2)之间呈正相关。结论:在FB计划中测得的TLV可能可用于预测心脏暴露并协助患者选择DIBH。这在资源分配中很重要,因为对于一些剂量学益处很小的患者可能不必要建议使用DIBH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号